C5 Antikörper (N-Term)
Kurzübersicht für C5 Antikörper (N-Term) (ABIN2215985)
Target
Alle C5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 253-281, N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- C5, NT (Complement C5, C3 and PZP-like alpha-2-macroglobulin Domain-containing Protein 4, Complement C5 beta Chain, Complement C5 alpha Chain, C5a Anaphylatoxin, Complement C5 alpha' Chain, CPAMD4)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 253-281 in the N-terminal region of human C5, UniProt Accession #P01031.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- C5 (Complement Component 5 (C5))
-
NCBI Accession
- NP_001726
-
UniProt
- P01031
-
Pathways
- Komplementsystem, Carbohydrate Homeostasis
Target
-